Monzosertib

N/A

Report date: 2024/12/20 11:49:00
NME

Base Information

Drug NameMonzosertib
Drug Alias NameAS-0141AS-141PNT-141SRA-141
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle 7-related protein kinase inhibitors
TargetsCell division cycle 7-related protein kinase
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesLymphoma, Large B-Cell, Diffuse +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMyelodysplastic SyndromesLymphoma, Large B-Cell, Diffuse +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A